Regulatory news: Nulibry (fosdenopterin) approved to reduce the risk of mortality in patients with molybdenum cofactor deficiency type A: FDA approval summary.
作者信息
Farrell Sheila, Karp Jacqueline, Hager Rebecca, Wang Yan, Adeniyi Oluseyi, Wang Jie, Li Liang, Ma Lian, Peretz Jackye, Summan Mukesh, Kong Nicolas, White Michael, Pacanowski Michael, Price Dionne, Filie Jane, Donohue Kathleen, Joffe Hylton
机构信息
Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
出版信息
J Inherit Metab Dis. 2021 Sep;44(5):1085-1087. doi: 10.1002/jimd.12421. Epub 2021 Aug 8.
PMID:34337775
Abstract
摘要
Zotero 插件